Cavalier Investments’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,252
Closed -$1.21M 80
2024
Q4
$1.21M Buy
31,252
+1,296
+4% +$50K 0.4% 41
2024
Q3
$1.35M Buy
+29,956
New +$1.35M 0.41% 55